Metabolomics News

Robust Metabolic Profiling for Routine Quantitation and Confident Unknown Identification  Technology Networks

Aditxt, Inc. and SphereDX Launch AditxtScore™ for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots  BioSpace

Aditxt, Inc. and SphereDX Launch AditxtScore™ for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots  Business Wire

Aditxt, Inc. and SphereDX Launch AditxtScore™ for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots  Yahoo Finance

STING-activating drugs could customise cancer treatments  Drug Target Review

Personal chemistry: Proteomics tackles privacy concerns  American Society for Biochemistry and Molecular Biology

Ginkgo Bioworks' Ferment Consortium Launches Verb Biotics, a Probiotics Innovation Company to Address Market Demands for Effective Probiotics  Yahoo Finance

Common medications accumulate in gut bacteria, which may reduce drug effectiveness and alter the gut microbiome  Science Daily

Study finds accumulation of common therapeutic drugs by gut bacteria  News-Medical.Net

Study finds accumulation of common therapeutic drugs by gut bacteria  News-Medical.Net

Common medications accumulate in gut bacteria, which may reduce drug effectiveness and alter the gut microbiome  Medical Xpress

Researchers Identify Mechanism That Can Help Guide Development of New STING-activating Drugs Using Imaging  Imaging Technology News

Global Idiopathic Pulmonary Fibrosis Disease Treatment Market Report 2020 with Focus on Esbriet (Pirfenidone) & Ofev (Nintedanib)  Yahoo Finance

Development of STING-Activating Drugs Guided by Imaging  Technology Networks

Development of STING-Activating Drugs Guided by Imaging  Technology Networks

Idiopathic Pulmonary Fibrosis Disease Treatment Global Markets 2020-2024 - ResearchAndMarkets.com  Business Wire

Idiopathic Pulmonary Fibrosis Disease Treatment Global Markets 2020-2024 - ResearchAndMarkets.com  Yahoo Finance

Global Idiopathic Pulmonary Fibrosis Disease Treatment Markets, 2018-2019 & 2020-2024  GlobeNewswire

Progenity (PROG) falls 3.60% to Close at $1.07 on September 7  Equities.com

Newly identified mechanism can accelerate the development of STING-activating drugs using imaging  News-Medical.net